Conatus Pharmaceuticals Inc. News
Count your blessings; bet on the banks: rev shark's best blog
Rev Shark steps in for Jim Cramer this week.
Futures point north, Asia mixed despite European attacks
Markets look set to continue their election rally as violence casts a pall over Europe.
Here's Why Conatus Pharmaceuticals (CNAT) Stock Is Soaring Today
Conatus Pharmaceuticals (CNAT) stock was boosted on Tuesday after Allergan (AGN) agreed to buy Tobira Therapeutics (TBRA) at a 500% premium.
Conatus Pharmaceuticals (CNAT) Stock Surges, Liver Drug Could Treat Zika
Conatus Pharmaceuticals' (CNAT) patented liver drug emricasan has been identified as a promising treatment for the Zika virus.
Conatus Pharmaceuticals (CNAT) Stock Soars on Positive Liver Drug Trial Results
Conatus Pharmaceuticals (CNAT) stock is increasing in mid-morning trading on Wednesday after the company said a Phase 2 trial of its liver drug showed positive results.
Disney Mobile Game Opens Up a New Universe
Familiar Disney characters populate an alternate reality in new interactive game.
Birth Control Stocks May Benefit From the Reversal of Roe v. Wade
The historic Supreme Court decision may force women to make different choices.
Roe Decision Forces Disney, Netflix to Take a Political Stand
Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.